Metformin and changes in serum lipid profile in lean patients with polycystic ovary syndrome
Kiałka, M.; Gałuszka-Bednarczyk, A.; Wajda, A.; Czekańska, P.; Zdzierak, B.; Mrozińska, S.; Janeczko, M.; Milewicz, T.
Przeglad Lekarski 74(4): 144-146
2017
ISSN/ISBN: 0033-2240 PMID: 29696950 Document Number: 692537
The aim of our study 32 patients received metformin 1500 mg per day in In lean patients with Our study showed that
Document emailed within 1 workday
Related Documents
Haydardedeoglu, B.; Simsek, E.; Kilicdag, E.B.; Bagis, T. 2009: Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 105(1): 32-35Mascitelli, L.; Pezzetta, F.; Goldstein, M.R. 2008: Metformin in polycystic ovary syndrome New England Journal of Medicine 358(17): 1867-1868; Author Reply 1868
Barbieri, R.L.; Gargiulo, A.R. 2004: Metformin for the treatment of the polycystic ovary syndrome Minerva Ginecologica 56(1): 63-79
Ozgurtas, T.; Oktenli, C.; Dede, M.; Tapan, S.; Kenar, L.; Sanisoglu, S.Y.; Yesilova, Z.; Yenen, M.C.; Erbil, M.K.; Baser, I. 2008: Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS) Atherosclerosis 200(2): 336-344
Anwary, S.A.; Alfazzaman, M.; Bari, N.; Islam, M.R. 2012: Outcome of metformin treatment in polycystic ovary syndrome Mymensingh Medical Journal: Mmj 21(1): 60-65
Petrányi, G. 2005: Treatment experience with metformin in polycystic ovary syndrome Orvosi Hetilap 146(21): 1151-1155
Aruna, J.; Mittal, S.; Kumar, S.; Misra, R.; Dadhwal, V.; Vimala, N. 2004: Metformin therapy in women with polycystic ovary syndrome International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 87(3): 237-241
Wang, H.-S. 2006: The role of metformin in the treatment of polycystic ovary syndrome (PCOS) Chang Gung Medical Journal 29(5): 445-447
Sengos, C.; Andreakos, C.; Iatrakis, G. 2000: Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome Clinical and Experimental Obstetrics and Gynecology 27(1): 35-38
Jakubowicz, D.J.; Iuorno, M.J.; Jakubowicz, S.; Roberts, K.A.; Nestler, J.E. 2002: Effects of metformin on early pregnancy loss in the polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 87(2): 524-529
Hwu, Y.M.; Lin, S.Y.; Huang, W.Y.; Lin, M.H.; Lee, R.K.K. 2005: Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 90(1): 39-43
Pekhlivanov, B.; Mitkov, M.; Kavŭrdzhikova, S. 2006: Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome Akusherstvo i Ginekologiia 45(6): 29-35
Iwata, M.Chiharu.; Porquere, L.; Sorpreso, I.C.Espósito.; Baracat, E.C.; Soares Júnior, Jé.Maria. 2015: Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome Revista da Associacao Medica Brasileira 61(3): 215-219
Zhao, J.-Z.; Lin, J.-J.; Yang, H.-Y.; Zhang, W.; Huang, X.-F.; Huang, Y.-P. 2010: Effects of oral contraceptives and metformin on the outcome of in vitro maturation in infertile women with polycystic ovary syndrome Journal of Women's Health 19(2): 261-265
Le Donne, M.; Alibrandi, A.; Giarrusso, R.; Lo Monaco, I.; Muraca, U. 2012: Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition Minerva Ginecologica 64(1): 23-29
Sayin, N.Cenk.; Gücer, F.; Balkanli-Kaplan, P.; Yüce, M.Ali.; Ciftci, Sürk.; Kücük, M.; Yardim, T. 2003: Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome Journal of Reproductive Medicine 48(3): 165-170
Wu, J.; Zhu, Y.; Jiang, Y.; Cao, Y. 2008: Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(7): 392-398
Harris-Glocker, M.; Davidson, K.; Kochman, L.; Guzick, D.; Hoeger, K. 2010: Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin Fertility and Sterility 93(3): 1016-1019
Bednarek-Tupikowska, G.; Milewicz, A.; Bolanowski, M.; Plamieniak, Z.; Bohdanowicz-Pawlak, A.; Amałowicz, B. 1991: Lipid disturbances in women with polycystic ovary syndrome Endokrynologia Polska 42(4): 595-601
Hoeger, K.; Davidson, K.; Kochman, L.; Cherry, T.; Kopin, L.; Guzick, D.S. 2008: The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials Journal of Clinical Endocrinology and Metabolism 93(11): 4299-4306